Skip to content

Apyx Medical Corporation APYX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Artivion logo
ArtivionAORT
AIR
AirSculpt Technologies, Inc.AIRS
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
AtriCure logo
AtriCureATRC
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's operating lease right-of-use assets in other assets?
Apyx Medical Corporation (APYX) reported operating lease right-of-use assets in other assets of $4.09M in Q1 2026.
How has Apyx Medical Corporation's operating lease right-of-use assets in other assets changed year-over-year?
Apyx Medical Corporation's operating lease right-of-use assets in other assets decreased by 10.7% year-over-year, from $4.58M to $4.09M.
What is the long-term trend for Apyx Medical Corporation's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Apyx Medical Corporation's operating lease right-of-use assets in other assets has grown at a 77.9% compound annual growth rate (CAGR), from $237K to $4.22M.